Navigation Links
Improving clinical use of stem cells to repair heart damage
Date:7/13/2010

Presenting at the UK National Stem Cell Network annual science conference today (13 July), Professor Michael Schneider describes a new approach to treating heart attack and cardiomyopathy using stem cells.

Professor Schneider, British Heart Foundation Professor at Imperial College London, said "Recent clinical trials using stem cells to treat heart damage have been successful in terms of safety but unfortunately the bone marrow stem cells used tend to give only a small improvement in how well the heart is pumping.

"We really want to use stem cells from the patients themselves that we know can give rise to beating heart cells and these are not found in bone marrow. The good news is that we're now finding ways to identify and purify such cells."

Around 1000 patients have been treated in approximately 20 trials worldwide, mostly using bone marrow stem cells or derivatives of bone marrow cells to repair damage caused by heart attack. There has also been a significant body of work looking at ways of producing beating heart cells from stem cells. The best proven approaches to creating new beating heart cells are using embryonic stem cells, induced pluripotent cells and heart-derived stem cells.

Professor Schneider continued: "Using heart-derived stem cells to treat heart attack and cardiomyopathy has some advantages over embryonic and induced pluripotent cells as they are potentially safer. It's also notable that of these three cell types, it's only heart-derived cells that are in current human clinical trials for this sort of treatment.

"The biggest challenge is to make an ideal product for transplant, which would be either a mixture of heart muscle- and blood vessel-forming cells or a pure population of some sort of precursor that could give rise to both muscle and blood vessel cells."

Professor Schneider's team have discovered a way to identify heart stem cells so as to purify them for transplant. They first d
'/>"/>

Contact: Nancy Mendoza
ukpo@uknscn.org
01-793-413-355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Page: 1 2

Related biology news :

1. Algae advances as a green alternative for improving water quality
2. Inventor honored for tech improving access to clean water, healthcare, and business development in India
3. Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
4. Improving the degradation of toxic hydrocarbons
5. New patented technology for improving cardiac CTs receives NIH support
6. Improving the odds
7. Improving livestock productivity in Honduras
8. Greatest thing since sliced bread: New data offer important clues toward improving wheat yields
9. High blood sugars impact on immune system holds clues to improving islet cell transplants
10. Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies
11. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... University of New Hampshire researchers will have two new ... of modeling space weather to advance their work, thanks ... grants to the university. The grants, totaling $1.35 million, will ... the Space Science Center in the Institute for the Study ...
... A team of researchers at Michigan State University has documented ... The results, published in the current issue of Nature ... how E. coli bacteria figured out how to ... of citrate. "It,s pretty nifty to see a new ...
... This month, GSA,s top geoscience journal, Geology, has ... include Bhutan; the James Bay Lowland of Canada; Mount ... New Mexico, USA; the Quelccaya Ice Cap, Peru; the ... micro-tunneling, fibrous diamonds, climate change, cosmic rays, and maars. ...
Cached Biology News:UNH labs receive 2 NSF grants totalling $1.35m for research instruments 2Evolution is as complicated as 1-2-3 2GEOLOGY adds 30 new articles online 2GEOLOGY adds 30 new articles online 3GEOLOGY adds 30 new articles online 4GEOLOGY adds 30 new articles online 5GEOLOGY adds 30 new articles online 6GEOLOGY adds 30 new articles online 7GEOLOGY adds 30 new articles online 8GEOLOGY adds 30 new articles online 9GEOLOGY adds 30 new articles online 10GEOLOGY adds 30 new articles online 11GEOLOGY adds 30 new articles online 12GEOLOGY adds 30 new articles online 13GEOLOGY adds 30 new articles online 14GEOLOGY adds 30 new articles online 15GEOLOGY adds 30 new articles online 16GEOLOGY adds 30 new articles online 17GEOLOGY adds 30 new articles online 18GEOLOGY adds 30 new articles online 19GEOLOGY adds 30 new articles online 20GEOLOGY adds 30 new articles online 21GEOLOGY adds 30 new articles online 22GEOLOGY adds 30 new articles online 23
(Date:3/3/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... Miami, FL on March 10, 2015 at ... Chief Financial Officer, will provide a corporate overview. ... Halozyme,s corporate website at www.halozyme.com , and a recording ... To access the live webcast, please log on to Halozyme,s ...
(Date:3/3/2015)... March 3, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... in Miami.   The live presentation takes ... PT).  The presentation will be webcast and may be ... Listeners are encouraged to visit the ...
(Date:3/3/2015)... March 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... the development of and commercialization of regenerative cell therapies ... announced today that it has received the final payment ... Holdings, Inc. (OTC Bulletin Board: AMBS ). ... made the final payments due to Regenicin in the ...
(Date:3/3/2015)... , March 3, 2015  Thingee Corporation, a ... be delivering a presentation entitled, "Technology Adoption: Making Reps, ... Thriving through Innovations and Technology ,  in ... 11 to 13, 2015. Audiences looking to learn how ... will want to be in the audience for the ...
Breaking Biology Technology:Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Thingee to present at 11th Annual Synergistix Users Conference 2
... ONTY ) (TSX: ONY) announced today that it ... common stock and warrants to purchase 2,909,244 shares of its ... May 26, 2009. Oncothyreon sold the shares and warrants for ... a warrant to purchase 0.75 shares of common stock). The ...
... Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: ... of Research and Development, will be presenting pre-clinical data from ... the American Society of Gene Therapy, which is being held ... from Wednesday, May 27th through to Saturday, May 30th, 2009. ...
... Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), ... for human disease, announced today that the company will be ... programs: LX1031 , an oral drug ... (IBS), and LX1032 , an ...
Cached Biology Technology:Oncothyreon announces closing of $11.1 million registered direct financing 2Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy 2Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy 3Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week 2Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week 3
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Biology Products: